ORIGINAL ARTICLE

Intravenous pamidronate treatment of infants with severe osteogenesis imperfecta

Eva Åström, Håkan Jorulf, Stefan Söderhäll

Department of Woman and Child Health, Astrid Lindgren Children’s Hospital, Karolinska Institute, Stockholm, Sweden

Correspondence to:
E Åström
Division of Paediatric Neurology, Astrid Lindgren Children’s Hospital, Karolinska University Hospital/Solna, 171 76 Stockholm, Sweden; eva.astrom{at}karolinska.se

Objective: Children with the severe forms of osteogenesis imperfecta have in several studies been treated with intravenous pamidronate, but there are only few reports of the effect of early treatment.

Aim: To evaluate the effect of treatment started in infancy.

Methods: In a prospective observational study, with a historic control group, intravenous disodium pamidronate (APD) was given as monthly infusions to 11 children with osteogenesis imperfecta aged 3–13 (median 3.6) months, who had severe osteogenesis imperfecta with congenital bowing of the femora and vertebral compression fractures.

Results: During treatment of children aged between 3 and 6 (median 4.5) years, dual-energy x ray absorptiometry measurements of the lumbar spine showed a gradual increase in bone density. Bone metabolism parameters in serum (alkaline phosphatase, osteocalcin, procollagen 1 carboxy-terminal peptide, collagen 1 teleopeptide) and in urine (deoxypyridinoline) indicated a decrease in bone turnover. An improvement of mobility was seen and at the latest recording, at the age of 3.3–6.5 (median 4.8) years, the children could all walk. Vertebral remodelling was seen, with increased vertebral height, and no child developed scoliosis, kyphosis or basilar impression. All children required femoral intramedullar rods for fractures, and five needed tibial rodding for extreme curvatures that prevented functional standing and walking. No adverse effects were seen on growth, fracture healing or blood chemistry.

Conclusions: APD is an efficient symptomatic treatment for infants with severe osteogenesis imperfecta, but additional orthopaedic surgery is often needed. Early treatment may prevent scoliosis and basilar impression. Long-term follow-up is important.

Abbreviations: ALP, alkaline phosphatase; APD, intravenous disodium pamidronate; DXA, dual-energy x ray absorptiometry; P1CP, procollagen 1 carboxy-terminal peptide 1CTP, collagen 1 teleopeptide

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Relevant Article

A brief digest of the April issue
Arch. Dis. Child. 2007 92: e4. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

• Senthilnathan, S, Walker, E, Bishop, N J (2008). Two doses of pamidronate in infants with osteogenesis imperfecta. Arch. Dis. Child. 93: 398-400 [Abstract] [Full Text]